Lisa Coussens, Elliott Levy, Patricia LoRusso named to inaugural Shasqi scientific advisory board; Jean-Frédéric Viret, Mukul Agarwal named to leadership roles

ODAC vote will likely lead to three-arm and four-arm designs–and pragmatic trials–for perioperative indications

The FDA Oncologic Drugs Advisory Committee July 25 voted unanimously to set more rigorous standards for new trials for approval of perioperative indications of cancer drugs.

July 26, 2024

Vol.50 No.30

By Jacquelyn Cobb and Paul Goldberg

In Brief

Sarah Bigelow named executive director of Tulane Cancer Center Clinical Trials Office

Sarah Bigelow was named executive director of the Clinical Trials Office at the Tulane Cancer Center.

July 05, 2024

Vol.50 No.27

Clinical

NCI’s Virtual Clinical Trials Office fills the staffing shortages at cancer centers

Cancer centers that continue to experience pandemic-induced shortages in staffing their clinical research enterprise may soon be able to rely on support from NCI’s Virtual Clinical Trials Office to open studies and accrue patients.

June 28, 2024

Vol.50 No.26

By Matthew Bin Han Ong

White House

At White House forum, Bertagnolli, Califf, Wegrzyn call for greater innovation in clinical trials

Leaders of three health agencies presented new initiatives focused on patient-centered research, diversity in clinical trial enrollment, and innovation in clinical research.

June 28, 2024

Vol.50 No.26

By McKenzie Prillaman

In Brief

Murphy, McKay, Nodora, Ballantyne, Stupack named associate directors at UCSD Moores

Diane Simeone, director of Moores Cancer Center at UC San Diego Health, has expanded her leadership team.

June 14, 2024

Vol.50 No.24

In Brief

MUSC Hollings opens phase I cancer clinical trials unit

MUSC Hollings Cancer Center has opened the Summer and Clyde Anderson Advanced Cancer Therapy Clinic to provide specialized care to patients participating in phase I clinical trials.

June 14, 2024

Vol.50 No.24

Lisa Coussens, Elliott Levy, Patricia LoRusso named to inaugural Shasqi scientific advisory board; Jean-Frédéric Viret, Mukul Agarwal named to leadership roles

YOU MAY BE INTERESTED IN

ODAC vote will likely lead to three-arm and four-arm designs–and pragmatic trials–for perioperative indications

Sarah Bigelow named executive director of Tulane Cancer Center Clinical Trials Office

NCI’s Virtual Clinical Trials Office fills the staffing shortages at cancer centers

At White House forum, Bertagnolli, Califf, Wegrzyn call for greater innovation in clinical trials

Murphy, McKay, Nodora, Ballantyne, Stupack named associate directors at UCSD Moores

MUSC Hollings opens phase I cancer clinical trials unit

Renew today!

Subscriber content

Login